Developers: | Accuray |
Date of the premiere of the system: | August 2023 |
Branches: | Pharmaceuticals, Medicine, Healthcare |
2023: Product Release
On August 9, 2023, Accurate Incorporated announced the release of the Radixact VitalHold system, developed to treat breast cancer on a deep breath.
Accurate Radixact is a fully integrated platform for intelligent treatment planning for cancer patients, centralized data management, and ultra-precise therapy delivery. The complex is versatile, making it possible to treat many malignant formations - from simple to complex tumors. Intelligent integration and automation accelerate planning, while a high-performance linear accelerator accelerates treatment.
VitalHold's solution in the Radixact platform facilitates breathing-controlled radiotherapy, a method that requires deep inhalation and breath holding (DIBH). VitalHold uses TomoDirect mode to deliver single beams without rotation. This allows for highly effective and accurate three-dimensional conformal radiation therapy (3D-CRT) and intensity-modulated radiotherapy (IMRT).
Treatment with DIBH helps to minimize radiation doses of organs at risk. As a result, the associated complications in later life decrease. During treatment, the patient takes a deep breath, moving the heart away from the chest wall and the target tumor. The system constantly monitors the patient's breathing and position with cameras to deliver radiation more efficiently. This method allows medical teams to maximize the outcome when performing procedures related to breast cancer. It is said that thanks to VitalHold, radiation therapy as an option for treating a breast tumor can be used at almost any stage.[1]